Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion

Bone Marrow Transplantation

Volumn 28, Issue 6, 2001, Pages 623-625

  Amrolia, P J ^a   Rao, K ^a   Slater, O ^a   Ramsay, A ^a   Veys, P A ^a   Webb, D K H ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Donor lymphocyte infusion; Graft versus host disease; HLA mismatched

Indexed keywords

ALEMTUZUMAB; ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HYDROXYUREA; METHYLPREDNISOLONE;

ACUTE DISEASE; ADOPTIVE IMMUNOTHERAPY; ARTICLE; CANCER RECURRENCE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; DONOR; ENTEROPATHY; FATALITY; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LIVER DISEASE; LYMPHOCYTE TRANSFUSION; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

BONE MARROW TRANSPLANTATION; CHILD; FATAL OUTCOME; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; LYMPHOCYTE TRANSFUSION; MALE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0034775445     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703195     Document Type: Article

References (18)

1. Mixed lymphohaematopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone marrow transplantation
2. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype
3. Transplantation of megadoses of purified haploidentical stem cells
4. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients
5. Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation
6. Comparison of single-dose and escalating-dose regimens of donor lymphocyte infusion for relapse after allografting for chronic myeloid leukemia
7. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
8. Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: Where we now stand
9. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: Separation of graft-versus-leukemia responses from graft-versus-host disease
10. Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation
11. Minor histocompatibility antigen-specific cytotoxic T cell lines, capable of lysing human hematopoietic progenitor cells, can be generated in vitro by stimulation with HLA-identical bone marrow cells
12. Analysis of the alloreactive T cell repertoire in man. I. Differences in precursor frequency for cytotoxic T cell responses against allogeneic MHC molecules in unrelated individuals
13. Mixed chimera converted into full donor chimera with powerful graft-versus-leukemia effects but no graft-versus-host disease after non T cell-depleted HLA-mismatched peripheral blood stem cell transplantation
14. Partially mismatched pediatric transplants with allogeneic CD34(+) blood cells from a related donor
15. Allogeneic bone marrow and peripheral stem cell transplantation from a haplo-identical mother and CD34 positive selection for CML
16. Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1
17. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia
18. Administration of herpes simplex-thymidine kinase-expressing donor T cells with a T-cell-depleted allogeneic marrow graft